| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 31-Mar-09 | 28-Dec-08 | | Total Revenue | 1,207,964 | 1,209,134 | 1,256,958 | 1,109,450 | | Cost of Revenue | 962,262 | 949,289 | 970,133 | 879,866 | | | Gross Profit | 245,702 | 259,845 | 286,825 | 229,584 | | | Operating Expenses | | Research Development | 15,886 | 15,378 | 18,284 | 16,105 | | Selling General and Administrative | 94,942 | 113,095 | 123,845 | 94,195 | | Non Recurring |
-
|
-
| 108,500 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 134,874 | 131,372 | 36,196 | 119,284 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 124 | 86 | 164 | 142 | | Earnings Before Interest And Taxes | 134,998 | 131,458 | 36,360 | 119,426 | | Interest Expense | 19,361 | 20,935 | 14,315 | 15,518 | | Income Before Tax | 115,637 | 110,523 | 22,045 | 103,908 | | Income Tax Expense | 43,020 | 41,040 | 54,655 | 38,947 | | Minority Interest | (107) | (52) | (142) | 61 | | | | Net Income From Continuing Ops | 72,510 | 69,431 | (32,752) | 65,022 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 72,510 | 69,431 | (32,752) | 65,022 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $72,510 | $69,431 | ($32,752) | $65,022 |
|
0.17% Nasdaq 
Income Statement
